Wei Ming Tang
Corporate Officer/Principal chez Vivere Lifesciences Acquisition Corp.
Profil
Dr. Wei Ming Tang is an Advisor at Vivere Lifesciences Acquisition Corp.
Dr. Tang was previously employed as a Chief Business Officer by I-Mab, an Executive Director & Business Director by Hengrui Therapeutics, Inc., a Vice President & Business Director by Crown Bioscience, Inc., and a Vice President & Business Director by Shanghai Biochip Co., Ltd.
He received his undergraduate degree from Zhejiang University, a graduate degree from Chinese Academy of Sciences and a doctorate degree from Rutgers State University of New Jersey.
Postes actifs de Wei Ming Tang
| Sociétés | Poste | Début |
|---|---|---|
Vivere Lifesciences Acquisition Corp.
 Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Corporate Officer/Principal | - |
Anciens postes connus de Wei Ming Tang
| Sociétés | Poste | Fin |
|---|---|---|
| I-MAB | Corporate Officer/Principal | 31/03/2024 |
| Hengrui Therapeutics, Inc. | Directeur/Membre du Conseil | 01/04/2018 |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/07/2015 |
Shanghai Biochip Co., Ltd.
 Shanghai Biochip Co., Ltd. BiotechnologyHealth Technology Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/07/2011 |
Formation de Wei Ming Tang
| Rutgers State University of New Jersey | Doctorate Degree |
| Zhejiang University | Undergraduate Degree |
| Chinese Academy of Sciences | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| I-MAB | Health Technology |
| Entreprise privées | 4 |
|---|---|
Crown Bioscience, Inc.
Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Commercial Services |
Shanghai Biochip Co., Ltd.
Shanghai Biochip Co., Ltd. BiotechnologyHealth Technology Shanghai Biochip Co., Ltd. (dba ShanghaiBio Corp.) performs specialty R&D services for global pharma/biotech companies. Situated on its own 10-acre campus in the heart of Shanghai's Zhangjiang Hi-Tech Park, China's Bio/Pharma Valley, ShanghaiBio operates in seven buildings totaling 220,000 SQF that contain offices and laboratories. Its labs provide GLP/GMP-compliant services and continually undergo rigorous internal and external QA audits. The scientific staff is chiefly home-grown talent trained by professionals schooled in western ways. The company was founded in August 2001 and is headquartered in Shanghai, China. | Health Technology |
| Hengrui Therapeutics, Inc. | |
Vivere Lifesciences Acquisition Corp.
Vivere Lifesciences Acquisition Corp. Financial ConglomeratesFinance Vivere Lifesciences Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Siu Wai Ng, Jie Lun Zhu and Ya Chun Chen on February 8, 2022 and is headquartered in Hong Kong. | Finance |
